Botulinum Toxin for Suspected Pseudoachalasia

Vallera, Raymond A.; Brazer, Scott R.
August 1995
American Journal of Gastroenterology;Aug1995, Vol. 90 Issue 8, p1319
Academic Journal
We describe a 74-yr-old man with stage III adenocarcinoma of the lung who presented with suspected malignancy-induced secondary achalasia and responded clinically to intrasphincteric injections of botulinum toxin type A (Botox, Allergen Inc., Irvine, CA). We discuss the use of botulinum toxin in this setting, as well as diagnostic strategies to differentiate achalasia from pseudoachalasia.


Related Articles

  • Single-session Botox safe, effective. Guttman, Cheryl // Dermatology Times;Apr2005 Supplement 2, Vol. 26, pS14 

    The article presents information related to Botulinum toxin type A (Botox, Botox Cosmetic; Allergan). Botox can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, although use of a higher dose affords benefits for...

  • Toxina botulínica para la secreción descontrolada de saliva: Presentación de un caso. DI NASSO, Patricia; BACCO RODRIGUEZ, José Luis; MANSILLA MONTENEGRO, Julio // Revista de la Facultad de Odontología. Universidad Nacional de ;2010, Vol. 4 Issue 1, p39 

    The botulinum neurotoxin is produced by the anaerobic bacterium clostridium botulinum (BoNT). It blocks neuromuscular transmission and for this reason it's used to treat diseases with muscular hyperactivity by blocking acetylcholine release and thus synaptic transmission at the neuromuscular...

  • Restraint helps avoid filler pitfalls. Jesitus, John // Dermatology Times;Sep2005, Vol. 26 Issue 9, p106 

    Focuses on the use of botulinum toxin as a complementary treatments for facial rejuvenation. Indications for botulinum toxin; Complications of the treatment; Recommendations on the administration of botulinum toxin.

  • Household Biowaste Containers (Bio-Bins) – Potential Incubators For Clostridium Botulinum and Botulinum Neurotoxins. Böhnel, Helge // Water, Air & Soil Pollution;Oct2002, Vol. 140 Issue 1-4, p335 

    In previously conducted research, Clostridium botulinum spores were found in bio-waste compost. Household bio-waste, collected in `bio-bins', was suspected to be one of the reasons for contamination. Maggots of Calliphoridae were collected inside and outside of bio-bins from 8 different...

  • Botulinum toxin in the management of acquired motor fusion deficiency. Murthy, Ramesh; Kesarwani, Siddharth // Indian Journal of Ophthalmology;Dec2009, Vol. 57 Issue 6, p463 

    Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption...

  • Botulinum Toxin Type B: Where Do We Stand? Dressler, Dirk // European Neurology;2001, Vol. 46 Issue 3, p113 

    Discusses issues concerning the therapeutic use of botulinum toxin (BT) type B. Comparison with the use of BT type A; Immunological considerations; Conversion factors.

  • Antibody-Induced Botulinum Toxin Therapy Failure: Can It Be Overcome by Increased Botulinum Toxin Doses? Dressler, Dirk; Münchau, Alexander; Bhatia, Kailash P.; Quinn, Niall P.; Bigalke, Hans // European Neurology;2002, Vol. 47 Issue 2, p118 

    In some patients treated with botulinum toxin type A (BT) therapy failure occurs due to the formation of antibodies against BT (BT-AB). We investigated whether increased BT doses can overcome this form of therapy failure. Eight patients with cervical dystonia, secondary BT therapy failure and...

  • Botulinum Toxin in Medical Therapy. Skorin Jr., Leonid // Review of Optometry;7/15/2004, Vol. 141 Issue 7, p53 

    Focuses on the use of botulinum toxin in medical therapy in the U.S. Treatment of blepharospasm, strabismus, and other ocular muscle disorders; Inhibition of the release of acetylcholine from the nerve terminal; Availability of two immunologically distinct neurotoxins for clinical use in the...

  • Crow's Feet Treatment with Botulinum Toxin Type A. Petropoulos, I.; Noussios, G.; Chouridis, P.; Kontzoglou, G.; Karagiannidis, K. // Internet Journal of Aesthetic & Antiaging Medicine;Oct2008, Vol. 1 Issue 2, p1 

    Botulinum toxin type A is widely used for treatment of facial rhytids, often in an "off-label" fashion. The most important mechanisms of action and safety concerns for such treatments are presented, with recommendations for treatment of periorbital rhytids.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics